Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

The KRAS gene mutation, responsible for a quarter of all cancerous tumors, has met its match. Thanks to UCSF research, a tiny ...

Immunotherapy—could that be an option for me, doctor?” is a question frequently asked by patients with colorectal cancer. The ...

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that ...

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

Colon cancer, also known as colorectal cancer, is one of the most frequent and aggressive cancers. According to the WHO, it ...

Total neoadjuvant treatment (TNT) may offer a promising alternative to surgery for patients with stage I rectal cancer (S1RC), a small study finds. 1 Among patients treated, TNT achieved a 93.7% ...

After surgery for colorectal cancer that’s started to spread beyond its initial location, many people go straight to treatment with chemotherapy. The idea behind this postsurgery, or adjuvant, ...

Patients with secondary rectal cancer (SRC) after radiotherapy (RT) for prostate cancer have shorter survival compared with matched treatment-naïve patients, (1) but factors explaining this gap have ...

Though still uncommon, rectal cancer is on the rise in young adults. Aug. 23, 2010— -- Rectal cancer is on the rise in American men and women under 40 -- although it remains uncommon, researchers ...